Tag: Johns Hopkins
-
Johns Hopkins Reveals Free Atlas of Immunotherapy Responses in Pancreatic Cancer and New Trial Findings
Overview: Free Atlas of Immunotherapy Responses in Pancreatic Cancer Johns Hopkins investigators have released a comprehensive, freely accessible atlas detailing how immunotherapies respond in pancreatic cancer. This resource aggregates data from diverse vaccine strategies and immune checkpoint inhibitors, shedding light on which therapies appear to provoke immune activity and how tumors may adapt. The release…
-
Johns Hopkins Unveils Free Atlas of Immunotherapy Responses in Pancreatic Cancer with New Trial Findings
Overview: A Free Atlas for Immunotherapy in Pancreatic Cancer Researchers at Johns Hopkins Medicine have released a comprehensive, freely accessible atlas detailing how pancreatic cancers respond to immunotherapy. The atlas, created from multiple clinical trials and ongoing studies, catalogs how different combinations of vaccines and immune checkpoint inhibitors influence tumor biology and patient outcomes. The…
-
New ultrasound technology cuts false positives in breast imaging
Groundbreaking approach helps differentiate fluid from solid masses A new ultrasound technology developed at Johns Hopkins is changing the way breast imaging is interpreted by accurately distinguishing fluid-filled cysts from solid masses. This capability addresses a long-standing challenge in breast ultrasound, where dense breast tissue can obscure or mimic suspicious findings, often leading to additional…
-
New Ultrasound Tech Cuts False Positives in Breast Exams
Revolutionary ultrasound technology from Johns Hopkins A new ultrasound innovation developed at Johns Hopkins offers a breakthrough in breast imaging. By differentiating fluid-filled areas from solid breast masses with near-perfect accuracy, the technology promises to dramatically reduce false positives that have long led to unnecessary biopsies and follow-up tests. How the technology works Traditional breast…
-
New Ultrasound Technology Reduces False Positives in Breast Imaging
A Breakthrough in Breast Imaging A pioneering ultrasound technology developed at Johns Hopkins is changing how clinicians distinguish fluid-filled from solid breast masses. In early trials, the method demonstrated near-perfect accuracy in classifying abnormalities, presenting a compelling advance for patients who undergo routine breast imaging. By reducing false positives, the new approach has the potential…
-
Even Social Smoking Can Trigger Heart Failure, Johns Hopkins Study Finds
New insights on an old habit When people think of smoking as a major health risk, they often picture heavy, daily use. Yet a growing body of research shows that even light, intermittent, or “social” smoking can significantly impact heart health. A Johns Hopkins study adds to the mounting evidence that no level of smoking…
-
Social Smoking Raises Heart Health Risk, Johns Hopkins Study Finds
Overview: Social smoking is not harmless A landmark study from Johns Hopkins University adds to the growing evidence that the health effects of tobacco extend well beyond heavy, daily smoking. Researchers found that even low-intensity, social smoking is associated with a noticeably higher risk of heart disease and premature death compared with abstinence. The findings…
-
Johns Hopkins Study Links Mild Pancreatic Duct Dilatation to Higher Cancer Risk
New findings spotlight a potential early warning sign Researchers at Johns Hopkins have explored how even mild dilatation of the pancreatic duct could be associated with an increased risk of pancreatic cancer. The study, which analyzed imaging data and patient outcomes, suggests that what doctors once considered a minor anatomical variation warrants closer attention when…
-
Mild Pancreatic Duct Dilatation Linked to Higher Cancer Risk, Johns Hopkins Study Finds
Understanding the Link Between Duct Dilation and Pancreatic Cancer Risk Pancreatic cancer remains one of the deadliest cancers, with rising incidence and late-stage discovery that often limits treatment options. A recent study from Johns Hopkins Medicine sheds light on a potential early warning sign: mild pancreatic duct dilatation. The finding suggests that even subtle changes…
-
Mild Pancreatic Duct Dilatation Signals Higher Cancer Risk, Johns Hopkins Study Finds
New Insights into Pancreatic Cancer Risk Pancreatic cancer remains one of the most deadly cancers, with the National Institutes of Health projecting pancreatic ductal adenocarcinoma to become the second-leading cause of cancer death in the United States by 2030. In this landscape, researchers at Johns Hopkins have explored whether a seemingly small anatomical change—the mild…